Subscribe to RSS
DOI: 10.1055/s-0029-1216908
Synthesis and Biological Evaluation of 6-Substituted Purinylcarbanucleosides with a Cyclopenta[b]thiophene Pseudosugar
Publication History
Publication Date:
14 July 2009 (online)

Abstract
The first members of a new family of heterocarbobicyclic nucleoside analogues have been synthesized from the cis/trans mixture of (4-amino-5,6-dihydro-4H-cyclopenta[b]thiophen-6-yl)methanols (cis/trans -7). The separation of the cis and trans intermediates during the preparation of the 6-chloropurine derivatives allowed a separate preparation of the purine heterocarbanucleosides cis-10 and trans-11, from which cis-12-14 and trans-16-18 were obtained by replacement of the 6-chloro substituent with amino, hydroxy, and cyclopropylamino groups. Additionally, the 6-phenylpurinyl analogues cis-15 and trans- 19 were prepared from cis-10 and trans-11 using Suzuki-Miyaura methodology. In tests of antiviral and cytostatic activities, compound 11 showed cytostatic activity against Molt4/C8 human T lymphoblastic leukemia cells. Antiviral activity was shown by compounds 15 and 19 against Punta Toro virus and Coxackie virus B4 (compound 11).
Key words
heterobicyclic amino alcohol - cyclopenta[b]thiophene - Suzuki-Miyaura cross-coupling reaction - purinylcarbanucleoside - biological activity
- 1a
Vermeire K.Schols D.Bell TW. Curr. Med. Chem. 2006, 13: 731 - 1b
De Clercq E. J. Med. Chem. 2005, 48: 1297 - 1c
De Clercq E. Front. Med. Chem. 2004, 1: 543 - 1d
Lazzarin A.Clotet B.Cooper D.Reynes J.Arastéh D.Nelson M.Katlama C.Stellbrink H.-J.Delfraissy J.-F.Lange J.Huson L.DeMasi R.Wat C.Delehanty J.Drobnes C.Salgo M. N. Engl. J. Med. 2003, 348: 2186 - 2
Mansour TS.Storer R. Curr. Pharm. Des. 1997, 3: 227 - 3a
Nucleoside Analogs in Cancer Therapy
Cheson BD.Keating MJ.Plunkett W. Marcel Dekker; New York: 1997. - 3b
De Clercq E. Clin. Microb. Rev. 1997, 10: 674 - 3c
De Clercq E. Curr. Med. Chem. 2001, 8: 1543 - 3d
Ena J.Pasquau F. Clin. Infect. Dis. 2003, 36: 1186 - 3e
Louie M.Hogan C.Di Mascio M.Hurley A.Simon V.Rooney J.Ruiz N.Brun S.Sun E.Perelson AS.Ho DD.Markowitz M. J. Infect. Dis. 2003, 187: 896 - 4
Balzarini J.Kang G.-J.Dala M.Herdewijn P.De Clercq E.Broker S.Johns DG. Mol. Pharmacol. 1987, 32: 162 - 5
Lea AP.Faulds D. Drugs 1996, 51: 846 - 6
Krayevsky AA.Watanabe KA. Modified Nucleosides as Anti-AIDS Drugs: Current Status and Perspectives Bioinform; Moscow: 1993. - 7
Thomas S.McDowall JE.Cheah V.Bye A.Segal MB. The Entry of Abacavir into the Guinea Pig Brain: Comparison with Other Reverse Transcriptase Inhibitors Presented at the 12th World AIDS Conference, Geneva; Italy: 1998. - For recent reviews of the biological properties of CNs, see:
- 8a
Cho JH.Bernard DL.Sidwell RW.Kern ER.Chu CK. J. Med. Chem. 2006, 49: 1140 - 8b
Schneller SW. Curr. Top. Med. Chem. 2002, 2: 1087 - 8c
Rodríguez JB.Comin MJ. Mini Rev. Med. Chem. 2003, 3: 95 - 8d
Ichicawa E.Kato K. Curr. Med. Chem. 2001, 8: 385 - 8e
Zhu X.-F. Nucleosides, Nucleotides Nucleic Acids 2000, 19: 651 - 8f
Agrofoglio L.Challand SR. Acyclic, Carbocyclic and l -Nucleosides Klewer Academic; Dordrecht: 1998. - 9
Crimmins MT.King BW. J. Org. Chem. 1996, 61: 4192 - 10a
Foster RH.Faulds D. Drugs 1998, 55: 729 - 10b
Daluge SM.Martín MT.Sickles BR.Livingston DA. Nucleosides, Nucleotides Nucleic Acids 2000, 19: 297 - 10c
Mahony WB.Domin BA.Daluge SM.Zimmerman TP. Biochem. Pharmacol. 2004, 68: 1797 - 10d
Opravil M.Hirschel B.Lazzarin A.Furrer H.Chave J.-P.Yerly S.Bisset LR.Fischer M.Vernazza P.Benasconi E.Battegay M.Ledergerber B.Günthard H.Howe C.Weber R.Perrin L. J. Infect. Dis. 2002, 185: 1251 - 11
Bisacchi GS.Chao ST.Bachard C.Daris JP.Innaimo S.Jacobs GA.Kocy O.Lapointe P.Martel A.Merchant Z.Slusarchyk WA.Sundeen JE.Young MG.Colonno R.Zahler R. Bioorg. Med. Chem. Lett. 1997, 7: 127 - 12
Wyatt PG.Anslow AS.Coomber BA.Cousins RPC.Evans DN.Gilbert VS.Humber DC.Paternoster IL.Sollis SL.Tapolczay DJ.Weingarten GG. Nucleosides Nucleotides 1995, 14: 2039 - 13a
Fernández F.García-Mera X.Morales M.Rodríguez-Borges JE. Synthesis 2001, 239 - 13b
Fernández F.García-Mera X.Morales M.Vilariño L.Caamaño O.De Clercq E. Tetrahedron 2004, 60: 9245 - 13c
Fernández F.García-Mera X.López C.Morales M.Rodríguez-Borges JE. Synthesis 2005, 3549 - 14a
Fernández F.García-Mera X.Morales M.Rodríguez-Borges JE.De Clercq E. Synthesis 2002, 1084 - 14b
Yao S.-W.Lopes VHC.Fernández F.García-Mera X.Morales M.Rodríguez-Borges JE.Cordeiro MNDS. Bioorg. Med. Chem. 2003, 11: 4999 - 15
Hocek M.Hol A.Votruba I.Dvoráková H. J. Med. Chem. 2000, 43: 1817 - 16a
García MD.Caamaño O.Fernández F.Abeijón P.Blanco JM. Synthesis 2006, 73 - 16b
Caamaño O.Gómez G.Fernández F.García MD.García-Mera X.De Clercq E. Synthesis 2004, 2855 - 16c
Hergueta AR.López C.García-Mera X.Fernández F. Tetrahedron 2004, 60: 10343 - 16d
García MD.Caamaño O.Fernández F.Figueira MJ.Gómez G. Synthesis 2003, 2138 - 16e
López C.Caamaño O.Hergueta AR.García MD.Fernández F. Tetrahedron Lett. 2002, 43: 5311 - 17
García MD.Caamaño O.Fernández F.López C.De Clercq E. Synthesis 2005, 925 - 18
García MD.Caamaño O.Fernández F.García-Mera X.Pérez-Castro I. Synthesis 2006, 3967 - 19a
Blanco JM.Caamaño O.Fernández F.Rodríguez-Borges JE.Balzarini J.De Clercq E. Chem. Pharm. Bull. 2003, 51: 1060 - 19b
Guan H.-P.Ksebati MB.Cheng YC.Drach JC.Kern ER.Zemlicka J. J. Org. Chem. 2000, 65: 1280 - 20
Abeijón P.Blanco JM.Fernández F.García MD.López C. Eur. J. Org. Chem. 2006, 759 - 21
Yoon NM.Brown HC. J. Am. Chem. Soc. 1968, 90: 2927 - 22a
Daluge S.Vince R. J. Org. Chem. 1978, 43: 2311 - 22b
Patil SD.Schneller SW.Hosoya M.Snoeck R.Andrei G.Balzarini J.De Clercq E. J. Med. Chem. 1992, 35: 3372 - 24
Cesnek M.Hocek M.Holy A. Collect. Czech. Chem. Commun. 2000, 65: 1357 - 25a
Hocek M. Eur. J. Org. Chem. 2003, 245 - 25b
Havelková M.Dvorak D.Hocek M. Synthesis 2001, 1704 - 25c
Havelková M.Hoces M.Cesnek M.Dovorák D. Synlett 1999, 1145 - 26
Suzuki A. J. Organomet. Chem. 1999, 576: 147 ; and references cited therein - 27
Walker SD.Barder TE.Martinelli JR.Buchwald SL. Angew. Chem. Int. Ed. 2004, 43: 1871 - 28
De Clercq E. In Vitro and Ex Vivo Test Systems to Rationalize Drug Design and DeliveryCromelin D.Couvreur P.Duchene D. Editions de Sante; Paris: 1994. p.108
References
CCDC-636456 contains the supplementary crystallographic data for compound trans-18 reported in this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.